These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival. Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860 [TBL] [Abstract][Full Text] [Related]
8. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mori M; Kohli A; Baker SP; Savas L; Fraire AE Mod Pathol; 1997 Jun; 10(6):572-7. PubMed ID: 9195574 [TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer]. Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038 [TBL] [Abstract][Full Text] [Related]
11. Cathepsin B in tumors, normal tissue and isolated cells from the human lung. Werle B; Ebert W; Klein W; Spiess E Anticancer Res; 1994; 14(3A):1169-76. PubMed ID: 8074469 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725 [TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Hsu CP; Shen GH; Ko JL Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461 [TBL] [Abstract][Full Text] [Related]
14. Activity and tissue localization of cathepsin D in non small cell lung cancer. Chyczewski L; Płoński A; Chyczewska E; Furman M; Ostrowska H; Nikliński J; Kozłowski M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539 [TBL] [Abstract][Full Text] [Related]
15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer. Khan A; Krishna M; Baker SP; Malhothra R; Banner BF Arch Pathol Lab Med; 1998 Feb; 122(2):172-7. PubMed ID: 9499362 [TBL] [Abstract][Full Text] [Related]
17. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746 [TBL] [Abstract][Full Text] [Related]
18. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Muley T; Dienemann H; Ebert W Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448 [TBL] [Abstract][Full Text] [Related]
20. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score. Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]